Buyouts = BIG $$$$$ for Shareholders!!!

Buyouts = BIG $$$$$ for Shareholders!!!


Better Load Up Everyone, BUYOUT SOON...


This is the only message now worth reading so I will be repeating it as

a public service announcement to shareholders...


The timeclock is ticking and soon all the wealthy former AVN (
http://www.avanir.com )shareholders will be the new Xenerex
shareholders...
THE BUYOUT COULD COME ANYTIME NOW...


Remember, retention rights for key employees expire in Sept. Former CEO

Yakatan already took his permanant vacation when he resigned.


Big pharma is looking for products and Neurodex is there. Shareholders
will profit nicely and Xenerex will stay with shareholders on the eve
of the US anthrax antibody contract. Shelf registration will allow
further product development. AVN shareholders are going to be filthy
rich and that's why biotech whiz kid Jonathan Silverstein has close to
9M shares AVN.


Time is running out and the game of musical chairs has begun. Don't be
left standing at the station as the train is about to pull out.


Here it is in black & white. I hope everyone has all their shares in
order. Time is running out and the big boys have been trying to take as

many shares as they can away from you before the BIG BUYOUT...


AVANIR (AVN) MERGER OR BUYOUT ON IT'S WAY...


Recent SEC filings for key employee retention rights seems to indicate
an AVN merger.


Either way, at less than $10 per share now, AVN looks like the best buy

around.


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
AVANIR PHARMACEUTICALS filed this from their recent 8-K


Item 1.01. Entry into a Material Definitive Agreement.
On September 17, 2004, Avanir Pharmaceuticals (the "Company") entered
into Retention Agreements with eight key employees (the "Employees").
The form of Retention Agreement (the "Agreement") and a list of the
Employees is attached hereto as Exhibit 99.1. The Agreement provides
certain severance benefits to each respective Employee if his or her
employment is terminated following a "change of control" (as defined)
of the Company. These severance benefits will be paid only if: (i) the
change of control occurs prior to September 30, 2005, (ii) the
termination of employment occurs within 12 months following the change
of control, and (iii) the termination was without "cause" or was a
"resignation for good reason" (as such terms are defined). If these
conditions are met for a given Employee, he or she will receive
severance payments equal to twelve months of base salary, plus an
amount equal to the aggregate bonus payment(s) received by such
Employee in the Company's preceding fiscal year. Additionally, he or
she will have the ability to extend the exercise period of outstanding
stock option awards, such that they will remain exercisable for 12
months from the date of termination.


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


After careful review, I am covinced that the technology employed by
AVN's subsidiary is distinctively superior than that employed by their
two biggest competitors of ABGX and PDLI. There are a few smaller
companies as well that can't even begin to compare. I believe that AVN
is completely undervalued and their Xenerex subsidiary alone will be
worth more than ABGX, PDLI and all the lessor companies combined. Other

than that, AVN itself has one of the most impressive drug development
pipelines with a potential blockbuster in Phase 3 and demonstrating
undisputably impressive results. Given a bit more time, AVN will hit a
grand slam if all falls into place. If anyone hasn't already done so,
do check out the data on AVN's anthrax antibody antidote. It will make
you think about the potential of AVN in fighting cancer and infectious
diseases in the future. AVN is a very solid company and completely
undervalued.


and don't forget:


Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar
blockbuster drug in Phase 3 with remarkable results up for FDA
Priority Approval, fantastic Anthrax Antibody, unique CancerCompound
unlike anything ever seen before, IgE for allergies and asthma,
Abreva herpes cream worldwide, unique Stem Cell patent, anti-
cholestoral drug,MIF tech, Xenerex subsidiary for the production of
the only completely human mABs.
http://www.avanir.com
http://www.xenerex.com

.